ETV4
Basic information
Region (hg38): 17:43527844-43579620
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ETV4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 41 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 20 | 20 | ||||
Total | 0 | 0 | 35 | 5 | 23 |
Variants in ETV4
This is a list of pathogenic ClinVar variants found in the ETV4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-43528547-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
17-43528581-A-G | not specified | Uncertain significance (Dec 15, 2022) | ||
17-43528586-G-C | not specified | Uncertain significance (Oct 10, 2023) | ||
17-43528623-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
17-43528638-G-A | not specified | Uncertain significance (May 29, 2024) | ||
17-43528665-G-A | Benign (Aug 01, 2022) | |||
17-43528676-G-A | Likely benign (Dec 14, 2017) | |||
17-43528730-C-T | Congenital anomaly of kidney and urinary tract | Likely pathogenic (Aug 24, 2018) | ||
17-43528880-T-C | Benign (Nov 11, 2018) | |||
17-43529343-G-A | Benign (Nov 11, 2018) | |||
17-43529554-T-C | not specified | Uncertain significance (Jan 25, 2023) | ||
17-43529617-C-T | not specified | Uncertain significance (Feb 17, 2024) | ||
17-43529628-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
17-43529634-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
17-43529652-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
17-43529905-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
17-43529905-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
17-43529943-T-C | not specified | Uncertain significance (Nov 08, 2022) | ||
17-43530108-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
17-43530116-C-A | not specified | Uncertain significance (Feb 22, 2023) | ||
17-43530602-ACG-A | Benign (Jun 19, 2021) | |||
17-43530609-C-T | Benign (Jun 18, 2021) | |||
17-43530609-CGTGTGTGT-C | Benign (Jun 18, 2021) | |||
17-43530635-T-A | Benign (Jun 18, 2021) | |||
17-43532694-G-A | not specified | Uncertain significance (Jul 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ETV4 | protein_coding | protein_coding | ENST00000319349 | 12 | 51777 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.87e-8 | 0.980 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.558 | 263 | 290 | 0.908 | 0.0000169 | 3135 |
Missense in Polyphen | 101 | 125 | 0.80799 | 1387 | ||
Synonymous | -0.132 | 126 | 124 | 1.01 | 0.00000768 | 950 |
Loss of Function | 2.22 | 17 | 30.1 | 0.564 | 0.00000161 | 306 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000420 | 0.000420 |
Ashkenazi Jewish | 0.000106 | 0.0000992 |
East Asian | 0.000871 | 0.000816 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000800 | 0.0000791 |
Middle Eastern | 0.000871 | 0.000816 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator that binds to the enhancer of the adenovirus E1A gene; the core-binding sequence is 5'[AC]GGA[AT]GT-3'. {ECO:0000269|PubMed:19307308}.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human);Androgen Receptor Network in Prostate Cancer;Signal Transduction;MAPK6/MAPK4 signaling;MAPK family signaling cascades;LKB1 signaling events
(Consensus)
Recessive Scores
- pRec
- 0.460
Intolerance Scores
- loftool
- 0.868
- rvis_EVS
- 0.29
- rvis_percentile_EVS
- 71.5
Haploinsufficiency Scores
- pHI
- 0.565
- hipred
- Y
- hipred_score
- 0.758
- ghis
- 0.475
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Etv4
- Phenotype
- renal/urinary system phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; neoplasm; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- etv4
- Affected structure
- pronephros
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;cell differentiation;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;nucleolus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding